Cellusion CEO Shin Hatou will speak at International Session 3 of the 78th Annual Congress of Japan Clinical Ophthalmology.

■The 78th Annual Congress of Japan Clinical Ophthalmology Date: November 14(Thu.) – 17 (Sun.), 2024
Venue: Kyoto International Conference Center (ICC Kyoto), The Prince Kyoto Takaragaike
Theme: Contribution to the future

■Hatou’s lecture
Thursday, November 14, 15:40-17:00, Room 5
International Session 3
Cornea Clinics Part 2: Surgical therapy -present and future-
Theme: Development of cell therapy for bullous keratopathy using iPS cells

Cellusion will participate in BIO Asia-Taiwan 2024, a gathering of bioindustry executives and investors from Asia and around the world, and CFO Takuya Kaneko is scheduled to make a pitch at the Investment Summit.
BIO Asia-Taiwan 2024
Investment Summit Session 4 / Pitch
Thursday, July 25, 2024, 10:50 a.m. – 12:30 p.m. (TST)
Venue: Nangang Exhibition Center, TaiNEX2 7F

Cellusion CEO Shin Hatou was interviewed for “NIKKEI NEWS NEXT,” a business news program produced by BS TV TOKYO and the Nikkei Group, a Japanese media conglomerate.
The program will be broadcast at the following time.
Friday, July 5, 2024, 9:54 p.m. – 10:54 p.m. (JST)
BS TV TOKYO “NIKKEI NEWS NEXT”
– Cornea Treatment With iPS Cells?　A Direct Interview With a Startup –

Cellusion will exhibit at HVC KYOTO (Healthcare Venture Conference KYOTO) 2024 Demo Day (Day2), an innovation platform organized by Kyoto Research Park Corp. (KRP) and Japan External Trade Organization (JETRO), co-hosted with Kyoto Prefecture and Kyoto City.
DemoDay Day2: Tuesday, July 9, 2024, 10:00 a.m. – 5:00 p.m.（JST）
Venue: Kyoto Research Park (93 Chudoji Awata-cho, Shimogyo-ku, Kyoto)

The core technology patent for Cellusion’s development product CLS001,
“Cell Seeding Agent And Material For Cell Transplantation” was granted in Japan

Cellusion CEO Shin Hatou will give a special lecture at the 6th Regenerative Medicine Expo TOKYO (June 26-28, 2024 at Tokyo Big Sight, Japan), where approximately 900 companies will exhibit regenerative medicine-related products and services.

Thursday, June 27, 4:00 p.m.-
Regenerative Medicine EXPO Special Session 4 / RM-S4
Lecture title: “Realization of New Corneal Regenerative Medicine Using iPS Cells”

Cellusion exhibits at the Japan Pavilion organized by JETRO
at the 2024 BIO International Convention

Cellusion receives “CGCS Pioneer Awards”
at “The 5th International Cell & Gene Therapy China Summit & Exhibition (CGCS2024)” held in Nanjing, China.

Cellusion CEO Shin Hatou was interviewed by NHK WORLD-JAPAN, the international service of NHK, the sole public media organization of Japan, for the program “Medical Frontiers” introducing groundbreaking Japanese medical technology and healthcare.
The broadcast times are as follows.
NHK WORLD-JAPAN May 20, 11:30 p.m.; May 21, 5:30 a.m., 12:30 a.m., 6:30 p.m.; May 25, 4:00 a.m. (JST)
NHK BS(101) June 22, 4:30 a.m. (JST) *All broadcasts will be in English

Cellusion CEO Shin Hatou will deliver a special lecture and participate in a panel discussion at ”The 5th International Cell & Gene Therapy China Summit & Exhibition” (CGCS2024 May 22-24, 2024), one of the largest cell and gene therapy events in APAC, to be held in Nanjing, China.